Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo

Inflammation Research

Volumn 46, Issue 5, 1997, Pages 180-184

  Reeves, J J ^a   Jones, C A ^a   Sheehan, M J ^a   Vardey, C J ^a   Whelan, C J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adenosine A3 receptors; Degranulation; Rat mast cells

Indexed keywords

2,4 DINITROPHENOL; 3 (4 AMINO 3 IODOBENZYL) 8 CYCLOPENTYL 1 PROPYLXANTHINE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 6 N [2 (4 AMINOPHENYL)ETHYL]ADENOSINE; 8 PHENYLTHEOPHYLLINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CARBON 14; COMPOUND 48-80; CYPROHEPTADINE; HUMAN SERUM ALBUMIN; IODINE 125; MONOCLONAL ANTIBODY; PLASMA PROTEIN; SEROTONIN; 4 METHOXY N METHYLPHENETHYLAMINE; 8-PHENYLTHEOPHYLLINE; 9 CHLORO 2 (2 FURYL) (1,2,4)TRIAZOLO(1,5 C)QUINAZOLIN 5 IMINE; 9-CHLORO-2-(2-FURYL)-(1,2,4)TRIAZOLO(1,5-C)QUINAZOLIN-5-IMINE; ADENOSINE; ADENOSINE RECEPTOR; BW A522; DRUG DERIVATIVE; N(6) (3 IODOBENZYL) 5' N METHYLCARBOXAMIDOADENOSINE; N(6)-(3-IODOBENZYL)-5'-N-METHYLCARBOXAMIDOADENOSINE; QUINAZOLINE DERIVATIVE; SEROTONIN ANTAGONIST; SERUM ALBUMIN; THEOPHYLLINE; TRIAZOLE DERIVATIVE; XANTHINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXTRAVASATION; FEMALE; MALE; MAST CELL DEGRANULATION; NONHUMAN; PLEURA; RAT; SEROTONIN RELEASE; ANIMAL; CYTOLOGY; DEGRANULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAST CELL; METABOLISM; MOUSE; PHYSIOLOGY; SKIN; WISTAR RAT;

ADENOSINE; ADMINISTRATION, CUTANEOUS; ANIMALS; BLOOD PROTEINS; CELL DEGRANULATION; CYPROHEPTADINE; DINITROPHENOLS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MAST CELLS; MICE; P-METHOXY-N-METHYLPHENETHYLAMINE; PLEURA; QUINAZOLINES; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; SEROTONIN; SEROTONIN ANTAGONISTS; SERUM ALBUMIN; SKIN; THEOPHYLLINE; TRIAZOLES; XANTHINES;

EID: 0030611258     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050169     Document Type: Article

References (21)

1. 3 receptor. Proc Natl Acad Sci USA 1992;89:7432-6.
2. Church MK, Hughes PJ, Vardey CJ. Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells. Br J Pharmacol 1986;87:233-42.
3. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 1993;268:16887-90.
4. 3 receptor-mediated hypotension in the rat. Br J Pharmacol 1995;115:945-52.
5. Eshhar Z, Ofarim M, Waks T. Generation of hybridomas secreting murine reagenic antibodies of anti-DNP specificity. J Immunol 1980;124:775-80.
6. Spector WG, Willoughby DA. The demonstration of the role of mediators in turpentine pleurisy in rats by experimental suppression of the inflammatory changes. J Path Bact 1959;77:1-17.
7. Vardey CJ. Studies on the biochemical and pharmacological control of anaphylaxis: A comparison of rat pleural mast cells and human lung fragments. PhD Thesis; Council for National Academic Awards: 1984.
8. 3 selective adenosine agonists. J Med Chem 1994;37:636-46.
9. Gurden MF, Coates J, Ellis F, Evans B, Foster M, Hornby E, et al. Functional characterisation of three adenosine receptor types. Br J Pharmacol 1993;109:693-8.
10. Ukena D, Schudt C, Sybrecht GW. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes. Biochem Pharmacol 1993;45:847-51.
11. Williams M, Francis J, Ghai G, Braunwalder A, Pyschoyos S, Stowe GA, et al. Biochemical characterization of the triazoloquinazoline, CGS15943, a novel, non-xanthine adenosine antagonist. J Pharmacol Exp Ther 1987;241:415-9.
12. 3 adenosine receptor. Proc Natl Acad Sci USA 1993;90:10365-9.
13. 2 adenosine receptors in atria and aorta from the guinea-pig. J Pharm Pharmac 1985;37:278-80.
14. 3-adenosine receptors. Drug Dev Res 1994;35:51-9.
15. Rollins PJ, Turner SJ, Akpoguma CIO, Ray KP. Characterisation of human adenosine type 1, 2a and 2b receptors expressed in CHO cells. Biochem Soc Trans 1994;22:195S.
16. 3 adenosine receptor. Molec Pharmacol 1994;45:1101-11.
17. 3 receptor agonist APNEA induces bronchospasm. Br J Pharmacol 1995;114:57P.
18. Merkel LA, Rivera LM, Colussi DJ, Perrone MH, Smits GJ, Cox BF. In vitro and in vivo characterisation of an A1-selective adenosine agonist, RG14202. J Pharmac Exp Ther 1993;265: 699-706.
19. 3 receptor. Br J Pharmacol 1994;113:741-8.
20. Marquardt DL, Parker CW, Sullivan TJ. Potentiation of mast cell mediator release by adenosine. J Immun 1978;120:871-8.
21. 3 adenosine receptor. Circulation Res 1996;786:627-34.